Equity

Prev Quarter Comp Home > Equity > Corporate Information > Prev Quarter Comp

Lupin LtdIndustry : Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code:500257 P/E (TTM) :19.2
ISIN Demat:INE326A01037 Div & Yield %:0.52 EPS (TTM) :120.99
Book Value (RS) :595.6712081 Market Cap (Rs Cr.):106180.28 Face Value (RS) :2
    Change Company 
Particulars Quarter Ended
(Dec 2025)
Quarter Ended
(Dec 2024)
Quarter Ended
(% Var)
Sales 4,433.96 4,060.16 9.21
Other Income 99.80 55.30 80.47
PBIDT 1,082.64 1,389.13 -22.06
Interest 36.02 19.55 84.25
PBDT 1,046.62 1,369.58 -23.58
Depreciation 178.68 152.52 17.15
PBT 867.94 1,217.06 -28.69
Tax 141.40 225.73 -37.36
Deferred Tax 9.09 6.66 36.49
PAT 717.45 984.67 -27.14

FOR GRIEVANCE MAIL TO invgrieviss@iseindia.com

BSE EQUITIES : INB011077733 | NSE F&O EQUITIES : INF231077737 | NSE CASH MARKET : INB231077737 | NSE CURRENCY DERIVATIVES : INE231077737 | MCX-SX : INE261077737

ISS Enterprise Limited [Erstwhile: ISE Securities & Services Limited], a wholly owned subsidiary of Inter-connected Stock Exchange of India Ltd. (ISE)

© 2013 ISS Enterprise Limited [Erstwhile: ISE Securities & Services Limited]. All rights reserved.

Designed, developed & powered by C-MOTS Infotech (ISO 9001:2008 certified)